Annovis Bio financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

애노비스 바이오NYSE:ANVS · New York Stock Exchange · Healthcare · sector #17

$1.18-1.67%

2026-10-06 close

Annovis Bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$27M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy